• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Palliative care services are underutilized at end of life in Ontario, Canada

byJayden BerdugoandAlex Chan
March 7, 2024
in Chronic Disease, Oncology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. In Ontario Canada, only 50% of home care clients received at least 1 or more palliative home care visits during their last 6 months of life.

2. The Risk Evaluation for Support: Predictions for Elder-life in their Communities Tool (RESPECT) served as a valuable prognostic model to provide early identification of palliative care needs.

 Evidence Rating Level: 2 (Good)

Palliative care is as essential service in the provision of holistic and patient-centred care for those diagnosed with life-limiting illnesses. Earlier initiation of palliative care has been linked with better outcomes such as improved quality of life and reduced distress. Despite this however, there is evidence that in Canada, as little as 15% of eligible individuals receive palliative care in their last year of life. This retrospective cohort study involved individuals 50 years or older (median age 80.1 [SD 11.0) years, mostly female [61.9%]) and examined their use of health care in Ontario. Within the first 6 months of the study, 29420 (11.9%) of the participants died. The median survival ranged from 30 days to 1576 days, and 98.1% in RESPECT risk bin 1 to 1.6% in risk bin 61. Only a few participants (2.6%) that were receiving home care, received a diagnosis of end-stage disease. The median survival was 58 (Interquartile range [IQR] 19-181) days for individuals with a median survival of less than 3 months, whereas the median survival for those predicted to live between 3 to 6 months was 144 (IQR 47-466) days, and 268 (IQR 79-826) days for those with a predicted median survival between 6 to 12 months. In all, this study corroborates prior literature that there is a poor utilization rate of palliative care resources in Canada.

Click to read the study in CMAJ

Image: PD

RELATED REPORTS

Simvastatin (Zocor) in combination with paclitaxel (Taxol) may provide treatment benefit compared to paclitaxel alone for small cell lung cancer

A multidisciplinary home-based intervention may reduce risk of falls after stroke

Pfizer’s Talzenna combo significantly delays prostate cancer progression

©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: end-of-lifehome careoncologypalliative carepublic health
Previous Post

Including e-cigarettes in smoking cessation counseling increases tobacco abstinence

Next Post

Mindfulness-Based Interventions May Be Comparable to Cognitive Behavioural Therapy At Improving ADHD-related Symptoms

RelatedReports

Thoracic radiotherapy improves survival in small-cell lung cancer patients
Chronic Disease

Simvastatin (Zocor) in combination with paclitaxel (Taxol) may provide treatment benefit compared to paclitaxel alone for small cell lung cancer

April 15, 2026
Intensive rehabilitation not superior to traditional therapy for arm function after stroke
Chronic Disease

A multidisciplinary home-based intervention may reduce risk of falls after stroke

April 3, 2026
Radiation plus hormone therapy may improve prostate cancer survival
Oncology

Pfizer’s Talzenna combo significantly delays prostate cancer progression

April 9, 2026
2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]
Endocrinology

2 Minute Medicine: Pharma Roundup – Pfizer’s Talzenna delays prostate cancer progression, apixaban lowers VTE bleeding risk, Lilly’s retatrutide hits Phase III metabolic targets, and FDA warns Novo Nordisk over safety reporting violations [March 2026]

March 30, 2026
Next Post
AAP recommends focus on nutrient-rich foods in schools

Mindfulness-Based Interventions May Be Comparable to Cognitive Behavioural Therapy At Improving ADHD-related Symptoms

#VisualAbstract: Inhibition of CD40L with Frexalimab in Multiple Sclerosis Reduces the Number of New Gadolinium-Enhancing T1 Weighted Lesion

#VisualAbstract: Inhibition of CD40L with Frexalimab in Multiple Sclerosis Reduces the Number of New Gadolinium-Enhancing T1 Weighted Lesion

Blood type correlates with egg reserve in infertile women

Elafibranor associated with biochemical response in patients with primary biliary cholangitis

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Tenecteplase (TNKase) may worsen functional outcomes in older patients with minor ischemic stroke
  • Jennifer Aniston’s “Strength for 50+” ritual spotlights red light therapy
  • Several serum proteins may provide prognostic value in metabolic dysfunction-associated steatotic liver disease
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

The Classics in Medicine Paperback Released!

Over the past 30 years, the transition from print to digital media has contributed to an exponential increase in medical literature. In response, 2 Minute Medicine presents 160+ authoritative, physician-written summaries of the most cited landmark trials in medicine.

amazon-logo_blackGet-it-on-iBooks-badge

Click anywhere to close this announcement

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.